(Q73635032)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751594%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751594%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

B Czartoryska

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751594%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751594%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

published in

Clinical Biochemistry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751594%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751594%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751594%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

147-149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751594%20AND%20SRC:MED&resulttype=core&format=json

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900098-3

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900098-3

Copper and ceruloplasmin metabolism in the LEC rat, an animal model for Wilson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900098-3

Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900098-3

Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900098-3

Serum chitotriosidase activity in Gaucher patients on enzyme replacement therapy (ERT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900098-3

Types I and III Gaucher disease in Poland: incidence of the most common mutations and phenotypic manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900098-3

Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900098-3

A practical approach to diagnosis and management of Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900098-3

10.1016/S0009-9120(99)00098-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751594%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference